IMM 1.23% 40.0¢ immutep limited

cvac patients posting trial progress, page-16

  1. 1,235 Posts.
    lightbulb Created with Sketch. 97
    Hello Digster

    Southoz said
    "Mainly because it seemed clear that there would not be an update for Overall Survival (OS) from Can-003 until the end of the year. "

    I have not been able to listen to the presentation you both reference and was wondering if you got the same impression regarding no OS update for CAN-003 is to be presented by Dr Gray at the ASCO meeting the end of next month.

    This seems to contradict the news from the company that they posted 28/3/2014
    "Dr. Gray will present the final progression-free survival data (PFS) and an update on overall survival (OS) from the Randomized, Open-Label Phase IIb Trial of Maintenance Therapy with a MUC1 Dendritic Cell Vaccine (CVacTM) for Epithelial Ovarian Cancer Patients in First or Second Remission (Prima protocol CAN-003)."
    Thanks in advance.
 
watchlist Created with Sketch. Add IMM (ASX) to my watchlist
(20min delay)
Last
40.0¢
Change
-0.005(1.23%)
Mkt cap ! $581.0M
Open High Low Value Volume
41.0¢ 41.5¢ 39.5¢ $1.576M 3.906M

Buyers (Bids)

No. Vol. Price($)
1 2506 39.5¢
 

Sellers (Offers)

Price($) Vol. No.
40.0¢ 8079 1
View Market Depth
Last trade - 16.10pm 13/09/2024 (20 minute delay) ?
IMM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.